AVNS

$13.61

Post-MarketAs of Mar 17, 8:00 PM UTC

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$13.61
Potential Upside
5%
Whystock Fair Value$14.29
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$632.91M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.09
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-9.07%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.17

Recent News

Zacks
Feb 25, 2026

Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y

AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Moby
Feb 24, 2026

Avanos Medical, Inc. Q4 2025 Earnings Call Summary

Moby summary of Avanos Medical, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Feb 24, 2026

Avanos Medical Inc (AVNS) Q4 2025 Earnings Call Highlights: Strong Specialty Nutrition Growth ...

Avanos Medical Inc (AVNS) reports robust full-year sales and strategic growth, while navigating tariff impacts and market shifts.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Feb 24, 2026

Avanos Medical Q4 Earnings Call Highlights

Avanos Medical (NYSE:AVNS) management said it delivered “solid” fourth-quarter and full-year 2025 results, pointing to progress on its strategic priorities and continued strength in its Specialty Nutrition Systems (SNS) business, while also outlining plans to mitigate tariff impacts and improve oper

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Feb 24, 2026

Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of +20.83% and +2.71%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.